Found 58 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50193995
(3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr...)Show SMILES C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N |r| Show InChI InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098427
(CHEMBL3593591)Show SMILES C[C@@H]1CCN(C[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O)C(=O)CC#N |r| Show InChI InChI=1S/C17H16N6O2/c1-10-4-7-22(14(24)2-5-18)9-13(10)23-15-11-3-6-19-16(11)20-8-12(15)21-17(23)25/h3,6,8,10,13H,2,4,7,9H2,1H3/t10-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098427
(CHEMBL3593591)Show SMILES C[C@@H]1CCN(C[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O)C(=O)CC#N |r| Show InChI InChI=1S/C17H16N6O2/c1-10-4-7-22(14(24)2-5-18)9-13(10)23-15-11-3-6-19-16(11)20-8-12(15)21-17(23)25/h3,6,8,10,13H,2,4,7,9H2,1H3/t10-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098427
(CHEMBL3593591)Show SMILES C[C@@H]1CCN(C[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O)C(=O)CC#N |r| Show InChI InChI=1S/C17H16N6O2/c1-10-4-7-22(14(24)2-5-18)9-13(10)23-15-11-3-6-19-16(11)20-8-12(15)21-17(23)25/h3,6,8,10,13H,2,4,7,9H2,1H3/t10-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098436
(CHEMBL3593579)Show SMILES C[C@@H]1CCCC[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C15H16N4O/c1-9-4-2-3-5-12(9)19-13-10-6-7-16-14(10)17-8-11(13)18-15(19)20/h6-9,12H,2-5H2,1H3/t9-,12+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098441
(CHEMBL3593584)Show SMILES Cl.CC[C@@H]1CCCC[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C16H18N4O/c1-2-10-5-3-4-6-13(10)20-14-11-7-8-17-15(11)18-9-12(14)19-16(20)21/h7-10,13H,2-6H2,1H3/t10-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50193995
(3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr...)Show SMILES C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N |r| Show InChI InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098441
(CHEMBL3593584)Show SMILES Cl.CC[C@@H]1CCCC[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C16H18N4O/c1-2-10-5-3-4-6-13(10)20-14-11-7-8-17-15(11)18-9-12(14)19-16(20)21/h7-10,13H,2-6H2,1H3/t10-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50193995
(3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr...)Show SMILES C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N |r| Show InChI InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098436
(CHEMBL3593579)Show SMILES C[C@@H]1CCCC[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C15H16N4O/c1-9-4-2-3-5-12(9)19-13-10-6-7-16-14(10)17-8-11(13)18-15(19)20/h6-9,12H,2-5H2,1H3/t9-,12+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098426
(CHEMBL3593592)Show SMILES C[C@@H]1CCN(C[C@@H]1n1c2c3cc[nH]c3ncc2n(C)c1=O)C(=O)CC#N |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098426
(CHEMBL3593592)Show SMILES C[C@@H]1CCN(C[C@@H]1n1c2c3cc[nH]c3ncc2n(C)c1=O)C(=O)CC#N |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 7.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098436
(CHEMBL3593579)Show SMILES C[C@@H]1CCCC[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C15H16N4O/c1-9-4-2-3-5-12(9)19-13-10-6-7-16-14(10)17-8-11(13)18-15(19)20/h6-9,12H,2-5H2,1H3/t9-,12+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098429
(CHEMBL3593590)Show SMILES O=C(CC#N)N1CCC[C@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C16H14N6O2/c17-5-3-13(23)21-7-1-2-10(9-21)22-14-11-4-6-18-15(11)19-8-12(14)20-16(22)24/h4,6,8,10H,1-3,7,9H2/t10-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098437
(CHEMBL3593580)Show SMILES C[C@H]1CCCC[C@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C15H16N4O/c1-9-4-2-3-5-12(9)19-13-10-6-7-16-14(10)17-8-11(13)18-15(19)20/h6-9,12H,2-5H2,1H3/t9-,12+/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098441
(CHEMBL3593584)Show SMILES Cl.CC[C@@H]1CCCC[C@@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C16H18N4O/c1-2-10-5-3-4-6-13(10)20-14-11-7-8-17-15(11)18-9-12(14)19-16(20)21/h7-10,13H,2-6H2,1H3/t10-,13+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098429
(CHEMBL3593590)Show SMILES O=C(CC#N)N1CCC[C@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C16H14N6O2/c17-5-3-13(23)21-7-1-2-10(9-21)22-14-11-4-6-18-15(11)19-8-12(14)20-16(22)24/h4,6,8,10H,1-3,7,9H2/t10-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098438
(CHEMBL3593581)Show InChI InChI=1S/C15H16N4O/c1-9-3-2-4-10(7-9)19-13-11-5-6-16-14(11)17-8-12(13)18-15(19)20/h5-6,8-10H,2-4,7H2,1H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098434
(CHEMBL3593577)Show InChI InChI=1S/C15H18N4O/c20-15-18-12-9-17-14-11(7-8-16-14)13(12)19(15)10-5-3-1-2-4-6-10/h7-10H,1-6H2,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098434
(CHEMBL3593577)Show InChI InChI=1S/C15H18N4O/c20-15-18-12-9-17-14-11(7-8-16-14)13(12)19(15)10-5-3-1-2-4-6-10/h7-10H,1-6H2,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098438
(CHEMBL3593581)Show InChI InChI=1S/C15H16N4O/c1-9-3-2-4-10(7-9)19-13-11-5-6-16-14(11)17-8-12(13)18-15(19)20/h5-6,8-10H,2-4,7H2,1H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098439
(CHEMBL3593582)Show SMILES CC1CCC(CC1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |(-.73,7.46,;-1.14,6.3,;-2.65,6.01,;-3.16,4.55,;-2.16,3.38,;-.64,3.67,;-.13,5.13,;-2.55,1.89,;-1.61,.73,;-2.41,-.59,;-1.66,-1.93,;,-1.91,;.68,-.57,;2.18,-.27,;2.36,1.23,;.98,1.89,;,.73,;-3.93,-.25,;-4.07,1.27,;-5.12,1.92,)| Show InChI InChI=1S/C15H18N4O/c1-9-2-4-10(5-3-9)19-13-11-6-7-16-14(11)17-8-12(13)18-15(19)20/h6-10H,2-5H2,1H3,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098439
(CHEMBL3593582)Show SMILES CC1CCC(CC1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |(-.73,7.46,;-1.14,6.3,;-2.65,6.01,;-3.16,4.55,;-2.16,3.38,;-.64,3.67,;-.13,5.13,;-2.55,1.89,;-1.61,.73,;-2.41,-.59,;-1.66,-1.93,;,-1.91,;.68,-.57,;2.18,-.27,;2.36,1.23,;.98,1.89,;,.73,;-3.93,-.25,;-4.07,1.27,;-5.12,1.92,)| Show InChI InChI=1S/C15H18N4O/c1-9-2-4-10(5-3-9)19-13-11-6-7-16-14(11)17-8-12(13)18-15(19)20/h6-10H,2-5H2,1H3,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098437
(CHEMBL3593580)Show SMILES C[C@H]1CCCC[C@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C15H16N4O/c1-9-4-2-3-5-12(9)19-13-10-6-7-16-14(10)17-8-11(13)18-15(19)20/h6-9,12H,2-5H2,1H3/t9-,12+/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098429
(CHEMBL3593590)Show SMILES O=C(CC#N)N1CCC[C@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C16H14N6O2/c17-5-3-13(23)21-7-1-2-10(9-21)22-14-11-4-6-18-15(11)19-8-12(14)20-16(22)24/h4,6,8,10H,1-3,7,9H2/t10-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098437
(CHEMBL3593580)Show SMILES C[C@H]1CCCC[C@H]1n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C15H16N4O/c1-9-4-2-3-5-12(9)19-13-10-6-7-16-14(10)17-8-11(13)18-15(19)20/h6-9,12H,2-5H2,1H3/t9-,12+/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098426
(CHEMBL3593592)Show SMILES C[C@@H]1CCN(C[C@@H]1n1c2c3cc[nH]c3ncc2n(C)c1=O)C(=O)CC#N |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098434
(CHEMBL3593577)Show InChI InChI=1S/C15H18N4O/c20-15-18-12-9-17-14-11(7-8-16-14)13(12)19(15)10-5-3-1-2-4-6-10/h7-10H,1-6H2,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098439
(CHEMBL3593582)Show SMILES CC1CCC(CC1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |(-.73,7.46,;-1.14,6.3,;-2.65,6.01,;-3.16,4.55,;-2.16,3.38,;-.64,3.67,;-.13,5.13,;-2.55,1.89,;-1.61,.73,;-2.41,-.59,;-1.66,-1.93,;,-1.91,;.68,-.57,;2.18,-.27,;2.36,1.23,;.98,1.89,;,.73,;-3.93,-.25,;-4.07,1.27,;-5.12,1.92,)| Show InChI InChI=1S/C15H18N4O/c1-9-2-4-10(5-3-9)19-13-11-6-7-16-14(11)17-8-12(13)18-15(19)20/h6-10H,2-5H2,1H3,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098432
(CHEMBL3593428)Show InChI InChI=1S/C14H16N4O/c19-14-17-11-8-16-13-10(6-7-15-13)12(11)18(14)9-4-2-1-3-5-9/h6-9H,1-5H2,(H,15,16)(H,17,19) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098432
(CHEMBL3593428)Show InChI InChI=1S/C14H16N4O/c19-14-17-11-8-16-13-10(6-7-15-13)12(11)18(14)9-4-2-1-3-5-9/h6-9H,1-5H2,(H,15,16)(H,17,19) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098435
(CHEMBL3593578)Show InChI InChI=1S/C15H18N4O/c20-15-18-12-8-17-14-11(6-7-16-14)13(12)19(15)9-10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098430
(CHEMBL3593588)Show SMILES CS(=O)(=O)N1CCC[C@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C14H15N5O3S/c1-23(21,22)18-6-2-3-9(8-18)19-12-10-4-5-15-13(10)16-7-11(12)17-14(19)20/h4-5,7,9H,2-3,6,8H2,1H3/t9-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098440
(CHEMBL3593583)Show SMILES OC(=O)C(O)=O.CC1(C)CCCCC1n1c2c(cnc3[nH]ccc23)[nH]c1=O Show InChI InChI=1S/C16H18N4O/c1-16(2)7-4-3-5-12(16)20-13-10-6-8-17-14(10)18-9-11(13)19-15(20)21/h6,8-9,12H,3-5,7H2,1-2H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098432
(CHEMBL3593428)Show InChI InChI=1S/C14H16N4O/c19-14-17-11-8-16-13-10(6-7-15-13)12(11)18(14)9-4-2-1-3-5-9/h6-9H,1-5H2,(H,15,16)(H,17,19) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098430
(CHEMBL3593588)Show SMILES CS(=O)(=O)N1CCC[C@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C14H15N5O3S/c1-23(21,22)18-6-2-3-9(8-18)19-12-10-4-5-15-13(10)16-7-11(12)17-14(19)20/h4-5,7,9H,2-3,6,8H2,1H3/t9-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098440
(CHEMBL3593583)Show SMILES OC(=O)C(O)=O.CC1(C)CCCCC1n1c2c(cnc3[nH]ccc23)[nH]c1=O Show InChI InChI=1S/C16H18N4O/c1-16(2)7-4-3-5-12(16)20-13-10-6-8-17-14(10)18-9-11(13)19-15(20)21/h6,8-9,12H,3-5,7H2,1-2H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 85 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098435
(CHEMBL3593578)Show InChI InChI=1S/C15H18N4O/c20-15-18-12-8-17-14-11(6-7-16-14)13(12)19(15)9-10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 88 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098440
(CHEMBL3593583)Show SMILES OC(=O)C(O)=O.CC1(C)CCCCC1n1c2c(cnc3[nH]ccc23)[nH]c1=O Show InChI InChI=1S/C16H18N4O/c1-16(2)7-4-3-5-12(16)20-13-10-6-8-17-14(10)18-9-11(13)19-15(20)21/h6,8-9,12H,3-5,7H2,1-2H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098433
(CHEMBL3593429)Show InChI InChI=1S/C13H14N4O/c18-13-16-10-7-15-12-9(5-6-14-12)11(10)17(13)8-3-1-2-4-8/h5-8H,1-4H2,(H,14,15)(H,16,18) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 97 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098433
(CHEMBL3593429)Show InChI InChI=1S/C13H14N4O/c18-13-16-10-7-15-12-9(5-6-14-12)11(10)17(13)8-3-1-2-4-8/h5-8H,1-4H2,(H,14,15)(H,16,18) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098425
(CHEMBL3593587)Show SMILES CS(=O)(=O)N1CCC(CC1)n1c2c(cnc3[nH]ccc23)[nH]c1=O Show InChI InChI=1S/C14H17N5O3S/c1-23(21,22)18-6-3-9(4-7-18)19-12-10-2-5-15-13(10)16-8-11(12)17-14(19)20/h2,5,8-9H,3-4,6-7H2,1H3,(H,15,16)(H,17,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098425
(CHEMBL3593587)Show SMILES CS(=O)(=O)N1CCC(CC1)n1c2c(cnc3[nH]ccc23)[nH]c1=O Show InChI InChI=1S/C14H17N5O3S/c1-23(21,22)18-6-3-9(4-7-18)19-12-10-2-5-15-13(10)16-8-11(12)17-14(19)20/h2,5,8-9H,3-4,6-7H2,1H3,(H,15,16)(H,17,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098433
(CHEMBL3593429)Show InChI InChI=1S/C13H14N4O/c18-13-16-10-7-15-12-9(5-6-14-12)11(10)17(13)8-3-1-2-4-8/h5-8H,1-4H2,(H,14,15)(H,16,18) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098430
(CHEMBL3593588)Show SMILES CS(=O)(=O)N1CCC[C@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C14H15N5O3S/c1-23(21,22)18-6-2-3-9(8-18)19-12-10-4-5-15-13(10)16-7-11(12)17-14(19)20/h4-5,7,9H,2-3,6,8H2,1H3/t9-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098442
(CHEMBL3593585)Show InChI InChI=1S/C13H14N4O2/c18-13-16-10-7-15-12-9(1-4-14-12)11(10)17(13)8-2-5-19-6-3-8/h1,4,7-8H,2-3,5-6H2,(H,14,15)(H,16,18) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098438
(CHEMBL3593581)Show InChI InChI=1S/C15H16N4O/c1-9-3-2-4-10(7-9)19-13-11-5-6-16-14(11)17-8-12(13)18-15(19)20/h5-6,8-10H,2-4,7H2,1H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098431
(CHEMBL3593589)Show SMILES CS(=O)(=O)N1CCC[C@@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C14H15N5O3S/c1-23(21,22)18-6-2-3-9(8-18)19-12-10-4-5-15-13(10)16-7-11(12)17-14(19)20/h4-5,7,9H,2-3,6,8H2,1H3/t9-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 460 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098442
(CHEMBL3593585)Show InChI InChI=1S/C13H14N4O2/c18-13-16-10-7-15-12-9(1-4-14-12)11(10)17(13)8-2-5-19-6-3-8/h1,4,7-8H,2-3,5-6H2,(H,14,15)(H,16,18) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098442
(CHEMBL3593585)Show InChI InChI=1S/C13H14N4O2/c18-13-16-10-7-15-12-9(1-4-14-12)11(10)17(13)8-2-5-19-6-3-8/h1,4,7-8H,2-3,5-6H2,(H,14,15)(H,16,18) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 520 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098425
(CHEMBL3593587)Show SMILES CS(=O)(=O)N1CCC(CC1)n1c2c(cnc3[nH]ccc23)[nH]c1=O Show InChI InChI=1S/C14H17N5O3S/c1-23(21,22)18-6-3-9(4-7-18)19-12-10-2-5-15-13(10)16-8-11(12)17-14(19)20/h2,5,8-9H,3-4,6-7H2,1H3,(H,15,16)(H,17,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 710 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098431
(CHEMBL3593589)Show SMILES CS(=O)(=O)N1CCC[C@@H](C1)n1c2c(cnc3[nH]ccc23)[nH]c1=O |r| Show InChI InChI=1S/C14H15N5O3S/c1-23(21,22)18-6-2-3-9(8-18)19-12-10-4-5-15-13(10)16-7-11(12)17-14(19)20/h4-5,7,9H,2-3,6,8H2,1H3/t9-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 850 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098435
(CHEMBL3593578)Show InChI InChI=1S/C15H18N4O/c20-15-18-12-8-17-14-11(6-7-16-14)13(12)19(15)9-10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,17)(H,18,20) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098428
(CHEMBL3593427)Show InChI InChI=1S/C14H19N3/c1-17(11-5-3-2-4-6-11)13-8-10-16-14-12(13)7-9-15-14/h7-11H,2-6H2,1H3,(H,15,16) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50098443
(CHEMBL3593586)Show InChI InChI=1S/C13H15N5O/c19-13-17-10-7-16-12-9(3-6-15-12)11(10)18(13)8-1-4-14-5-2-8/h3,6-8,14H,1-2,4-5H2,(H,15,16)(H,17,19) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK3 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098443
(CHEMBL3593586)Show InChI InChI=1S/C13H15N5O/c19-13-17-10-7-16-12-9(3-6-15-12)11(10)18(13)8-1-4-14-5-2-8/h3,6-8,14H,1-2,4-5H2,(H,15,16)(H,17,19) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM50098428
(CHEMBL3593427)Show InChI InChI=1S/C14H19N3/c1-17(11-5-3-2-4-6-11)13-8-10-16-14-12(13)7-9-15-14/h7-11H,2-6H2,1H3,(H,15,16) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK2 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM50098428
(CHEMBL3593427)Show InChI InChI=1S/C14H19N3/c1-17(11-5-3-2-4-6-11)13-8-10-16-14-12(13)7-9-15-14/h7-11H,2-6H2,1H3,(H,15,16) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Astellas Pharma Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human JAK1 kinase domain using biotin-Lyn-substrate-2 as substrate and ATP incubated for 1 hr by ELISA method |
Bioorg Med Chem 23: 4846-59 (2015)
Article DOI: 10.1016/j.bmc.2015.05.028
BindingDB Entry DOI: 10.7270/Q2SX6G04 |
More data for this
Ligand-Target Pair | |
Search and Browse
